文献速递血栓与止血

F8基因部分重复(FVIII Padua)与高FVIII水平及家族性血栓倾向相关

Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia.
PubMed 文献 · Blood · 2021-01-01

研究在两个意大利重度血栓倾向家系中探索高凝血因子VIII水平的遗传基础,发现F8基因近端区域23.4-kb串联重复与高FVIII水平共分离,携带者F8 mRNA上调≥2倍,并定位到内含子1中927-bp增强子区域,命名为FVIII Padua。

要点

  • F8基因近端23.4-kb串联重复可导致FVIII抗原和活性持续>400%。
  • 该重复在103名正常对照中缺失,并在第二个家系中检出相同重组。
  • 重复区域含开放染色质和增强子特征,内含子1的927-bp区使报告基因活性增加>45倍。

核心结论

  • 首次报告F8基因致血栓缺陷FVIII Padua,与FVIII水平显著升高及两个意大利家系的重度血栓倾向相关。

研究设计与样本

  • 研究纳入两个意大利重度血栓倾向家系,并对50例FVIII≥250%的无血缘VTE患者进行靶向筛查。

主要发现

  • 第一家系先证者50岁前反复VTE,FVIII抗原和活性持续>400%,为唯一血栓缺陷。
  • 遗传分析发现F8基因启动子、外显子1及内含子1大部分区域的23.4-kb串联重复,与高FVIII水平共分离。
  • 该重复在103名正常对照中缺失,第二个家系检出相同F8重组且遗传背景相同,提示奠基者效应。
  • 两个家系携带者F8 mRNA上调≥2倍,与重复区域内开放染色质特征和增强子元件一致。
  • 荧光素酶报告实验定位内含子1中927-bp区域,在内皮细胞中使报告活性增加>45倍。

关键数值与推荐

  • FVIII抗原和活性>400%为先证者唯一血栓缺陷。
  • 靶向筛查50例无血缘VTE患者,入选条件为FVIII水平≥250%。
  • 重复大小为23.4-kb,在103名正常对照中缺失。
  • 携带者F8 mRNA上调≥2倍;927-bp内含子1区域使报告活性增加>45倍。

临床怎么用

  • 对年轻反复VTE且FVIII水平显著升高者,可考虑F8基因结构变异检测。
  • FVIII Padua可作为家族性血栓倾向的遗传标志,携带者需评估血栓风险。

局限性

  • 研究仅基于两个意大利家系和有限的无血缘VTE筛查样本。
  • 927-bp增强子区域的功能证据来自体外荧光素酶报告实验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High coagulation factor VIII (FVIII) levels comprise a common risk factor for venous thromboembolism (VTE), but the underlying genetic determinants are largely unknown. We investigated the molecular bases of high FVIII levels in 2 Italian families with severe thrombophilia. The proband of the first family had a history of recurrent VTE before age 50 years, with extremely and persistently elevated FVIII antigen and activity levels (>400%) as the only thrombophilic defects. Genetic analysis revealed a 23.4-kb tandem duplication of the proximal portion of the F8 gene (promoter, exon 1, and a large part of intron 1), which cosegregated with high FVIII levels in the family and was absent in 103 normal controls. Targeted screening of 50 unrelated VTE patients with FVIII levels ≥250% identified a second thrombophilic family with the same F8 rearrangement on the same genetic background, suggesting a founder effect. Carriers of the duplication from both families showed a twofold or greater upregulation of F8 messenger RNA, consistent with the presence of open chromatin signatures and enhancer elements within the duplicated region. Testing of these sequences in a luciferase reporter assay pinpointed a 927-bp region of F8 intron 1 associated with >45-fold increased reporter activity in endothelial cells, potentially mediating the F8 transcriptional enhancement observed in carriers of the duplication. In summary, we report the first thrombophilic defect in the F8 gene (designated FVIII Padua) associated with markedly elevated FVIII levels and severe thrombophilia in 2 Italian families.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Simioni P, Cagnin S, Sartorello F, et al. Partial F8 gene duplication (factor VIII Padua) associated with high factor VIII levels and familial thrombophilia. Blood. 2021. PMID: 33275657. doi:10.1182/blood.2020008168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。